UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

Nature reviews cardiology, 2022-02, Vol.19 (2), p.75-77

2022

Volltextzugriff (PDF)

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Nature (London), 2021-04, Vol.592 (7853), p.283-289

2021

Volltextzugriff (PDF)

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Nature (London), 2021-08, Vol.596 (7872), p.417-422

2021

Volltextzugriff (PDF)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Nature communications, 2021-05, Vol.12 (1), p.2893-2893, Article 2893

2021

Volltextzugriff (PDF)

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Nature medicine, 2021-06, Vol.27 (6), p.1062-1070

2021

Volltextzugriff (PDF)

CureVac COVID vaccine let-down spotlights mRNA design challenges

Nature (London), 2021-06, Vol.594 (7864), p.483-483

Dolgin, Elie

2021

Volltextzugriff (PDF)

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection

Nature reviews. Microbiology, 2016-01, Vol.14 (1), p.45-54

2016

Volltextzugriff (PDF)

How COVID unlocked the power of RNA vaccines

Nature (London), 2021-01, Vol.589 (7841), p.189-191

Dolgin, Elie

2021

Volltextzugriff (PDF)

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

Nature communications, 2020-08, Vol.11 (1), p.4207-4207, Article 4207

2020

Volltextzugriff (PDF)

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

Emerging microbes & infections, 2021, Vol.10 (1), p.629-637

2021

Volltextzugriff (PDF)

A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy

Nature communications, 2020-04, Vol.11 (1), p.1985-15, Article 1985

2020

Volltextzugriff (PDF)

Could mixing COVID vaccines boost immune response?

Nature (London), 2021-02, Vol.590 (7846), p.375-376

Ledford, Heidi

2021

Volltextzugriff (PDF)

A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2

Nature communications, 2021-02, Vol.12 (1), p.776-776, Article 776

2021

Volltextzugriff (PDF)

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses

Nature materials, 2011-03, Vol.10 (3), p.243-251

2011

Volltextzugriff (PDF)

Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles

Nature nanotechnology, 2016-10, Vol.11 (10), p.890-899

2016

Volltextzugriff (PDF)

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Nature communications, 2024-05, Vol.15 (1), p.4081-13, Article 4081

2024

Volltextzugriff (PDF)

Stalking influenza by vaccination with pre-fusion headless HA mini-stem

Scientific reports, 2016-03, Vol.6 (1), p.22666-22666, Article 22666

2016

Volltextzugriff (PDF)

Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii

Scientific reports, 2016-02, Vol.6 (1), p.20724-20724, Article 20724

2016

Volltextzugriff (PDF)

Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history

Scientific reports, 2021-08, Vol.11 (1), p.17325-17325, Article 17325

2021

Volltextzugriff (PDF)

A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice

Nature chemical biology, 2014-11, Vol.10 (11), p.950-956

2014

Volltextzugriff (PDF)

Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis

Scientific reports, 2024-09, Vol.14 (1), p.22631, Article 22631

2024

Volltextzugriff (PDF)

Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response

Emerging microbes & infections, 2021-01, Vol.10 (1), p.365-375

2021

Volltextzugriff (PDF)

Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine

Scientific reports, 2016-06, Vol.6 (1), p.27944-27944, Article 27944

2016

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

KollektionNorth East Research Libraries Nature Academic Titles

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(94)
magazinearticle
(2)

Sprache

Englisch
(96)

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Vaccines, Synthetic - Administration & Dosage
(75)
Vaccines, Synthetic - Immunology
(66)
Animals
(64)
Humans
(58)
Vaccines
(53)
Life Sciences & Biomedicine
(48)
Female
(40)
Science & Technology - Other Topics
(37)
Mice
(36)
Multidisciplinary Sciences
(36)
Vaccines, Synthetic - Genetics
(30)
Antibodies
(29)
Immunization
(25)
Antibodies, Viral - Immunology
(24)
Vaccination
(24)
Male
(23)
Covid-19 Vaccines - Administration & Dosage
(22)
Covid-19 Vaccines - Immunology
(21)
Antibodies, Neutralizing - Immunology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(96)
Nature Journals Online
(96)
EZB Electronic Journals Library
(54)
Ingenta
(52)
Nexis Uni
(46)
Publisher
(36)
Journals@Ovid Full Text
(28)
IngentaConnect Journals
(27)
EBSCOhost Psychology and Behavioral Sciences Collection
(14)
Taylor & Francis Journals
(7)
Wiley-Blackwell Journals
(4)
EBSCOhost Business Source Ultimate
(2)
JSTOR
(2)

8 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Scientific Reports
(19)
Nature
(13)
Nature Communications
(9)
Nature Biotechnology
(8)
Nature Medicine
(8)
Emerging Microbes & Infections
(7)
Gene Therapy
(5)
Bio/technology
(3)
Cancer Gene Therapy
(3)
The American Journal Of Gastroenterology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

CureVac COVID vaccine let-down spotlights mRNA design challenges

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection

How COVID unlocked the power of RNA vaccines

A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy

Could mixing COVID vaccines boost immune response?

A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses

Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Stalking influenza by vaccination with pre-fusion headless HA mini-stem

Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii

Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history

A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice

Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis

Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response

Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine

Aktive Filter

Suchergebnisse filtern